Hepatitis C misdiagnosis rate as high as 9 into!
Hepatitis C is a chronic progressive disease, early symptoms of occult, the patient is very easy to overlook. And the Hospital General Surgery, Hematology, Gastroenterology and other diagnosed of hepatitis C virus antibody-positive patients were also many infected subjects due to failure or liver disease subjects to review and misdiagnosis, resulting in the majority of patients when treatment has been developed for the liver sclerosis and even liver cancer, missed the best time of their treatment. Vice president of Peking University People’s Hospital, liver specialist Professor Wei Lai pointed out that in the first diagnosis on the basis of accountability, should actively promote rational referral system, establishment of hospitals, mutual cooperation among the various sections of the health care system, to ensure that patients in the first a time to receive standard treatment.
Lack of public knowledge of hepatitis C, the lower the rate of newly diagnosed
It is understood that China is currently about 40 million hepatitis C patients, infection rate of 3.2% in 2008 reported the incidence of hepatitis C more than 10 million, compared with 2006, an increase of 30.01%. Because hepatitis C caused by the burden of disease and death toll is doubled.
A “hepatitis C awareness survey” results showed that: only 1% of the people of the hepatitis C transmission, prevention measures, and so have a correct understanding; 76% of the respondents do not understand hepatitis C be cured; 80 % of the respondents even mistakenly believe that “vaccine-preventable hepatitis.” The public awareness of HCV so low, making hepatitis C treatment rate is only 10%. Professor Wei Lai said: “to raise public awareness, strengthening hospital referral and review, will greatly enhance the rate of hepatitis C treatment is to ensure and improve the early diagnosis of hepatitis C the first step.”
Early hospital referral and review, the cure rate of up to 70% of hepatitis C
Hepatitis C in the development of liver cirrhosis or liver cancer before, they can have up to 20 years to 30 years in hiding period of development, some patients showed only fatigue.
Professor Wei Lai pointed out that the high-risk groups should be regularly checked. Who received blood transfusions, used non-disposable syringes and sterile without the strict dental, endoscopy, hemodialysis, organ transplants, patients with hepatitis C before sharing razors, there have been dirty sexual history, intravenous injecting drug users, or have had tattoos and other skin and mucosal injury in hepatitis C at high risk groups of people Jie Wei.
Many hepatitis C patients in surgical departments to do preoperative examination, hematological do blood tests, liver function tests done Gastroenterology, Nephrology, do kidney dialysis, it will be detected hepatitis C virus antibody-positive patients as soon as possible to the infected branches or liver Disease Branch review, early diagnosis and treatment. Under the current international gold standard for treatment of hepatitis C: pegylated interferon + ribavirin, using adequate doses of one year of therapy, hepatitis C cure rate can reach 78 into.
Hepatitis C is a curable disease, its treatment program has been included in the scope of the basic medical insurance reimbursement, patient medication is no longer difficult.
Interferon with specific cell surface receptors, thereby inhibiting the infected cells of viral replication and cell proliferation, and a role in immune regulation, blocking the spread of hepatitis viruses. The latest international research data prove that, unlike chronic hepatitis B, some patients with incurable hepatitis C, after the success of pegylated interferon treatment of hepatitis C patients after stopping an average follow-up to 4.1 years, 99% of patients with efficacy lasting, that is achieved clinical cure effect.
According to Professor Wei Lai introduced from May 1, 2007, the hepatitis C patients with pegylated interferon treatment into Medicare Beijing, Peking University People’s Hospital has been designated as hepatitis C sentinel health-care unit. In addition, the national “Eleventh Five-Year” major scientific and technological projects have also to include hepatitis C prevention and control, Peking University People’s Hospital as the responsible unit, the subject for the national “Eleventh Five-Year” key support for the project, and will recruit more than 3,000 nationwide hepatitis C patients, some of the cost of treatment paid by the State of hepatitis C patients have the appropriate gifts drug policy, which in large measure to alleviate the economic burden of hepatitis C patients. Therefore, the hepatitis C drug is no longer facing an economic high-threshold problems, patients can more safely conventional medication. Morning News reporters Xing Yushu and Chen Jing
People’s Hospital consultation activities organized by missionaries
Peking University People’s Hospital specific to August 1, 2009 AM 8:30-12:00 at the Peking University People’s Hospital outpatient building at 5th Floor, Lecture Hall missionary academic advisory activities. By then, will be led by Professor Wei Lai and liver specialists of the Institute for the sufferers to provide free hepatitis C antibodies and hepatitis C prevention and treatment of related issues such as consultation.